We apologize! The document was not able to download due to an unknown error. Our team has been notified and we will fix it as soon as possible. Fill out the form below, and we will send you the document as soon as we can!
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is an advanced controlled drug release agent form Evonik containing 50 mol % D,L-lactide and 50 mol % Glycolide with no added preservatives. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 has an inherent viscosity range of 0.15─0.25 dL/g in HFIP and a degradation period of 3 months.
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is a 100% bioresorbable PLGA-based copolymer available as a white to light tan granule solid pellet with an inherent viscosity of 0.15─0.25 dL/g in HFIP. As part of Evonik's LACTEL® polymer line, it offers exceptional controlled release of pharmaceutical ingredients in long-acting injectable formulations for human generic drug formulations and veterinary medicine with high functionality and advanced metabolization in the body. It offers a cost-effective option, available in small volumes and can be optimized to meet progress requirements. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is non-GMO and contains no added preservatives.
Specifications
Physical state: Solid Form: Granules Color: White to light tan Inherent viscosity (IV) dL/g: 0.15─0.25 (in HFIP) Degradation time: <3 months Density (g/mL): 1.34 Tensile Strength (psi): 6000─8000 Elongation (%): 3─10 Modulus (psi): 2─4x10⁵ CAS no. 26780-50-7
Primary Chemistry: Poly(DL-lactide-co-glycolide)
Features & Benefits
50:50 ratio of D,L-Lactide and Glycolide Ester end group No added preservatives Non-GMO Amorphous 3 month degradation period Bioabsorbable excipient Suitable for use with small molecules, peptides, proteins, and other substances Unpurified Cost-effective Non-GMO
Applications
Human generic drug formulations Long-acting injectable formulations Price sensitive applications veterinary medicine
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region:
English - United States
Hi, let us know if you have any questions as you visit our website.
